Core Viewpoint - The company announced the issuance of a super short-term financing bond in the interbank bond market, indicating a strategic move to raise funds for operational needs [1] Group 1: Financing Details - The company will issue the 2025 Annual 7th Phase super short-term financing bond on November 19, 2025, with a total issuance amount of 1 billion yuan [1] - Each bond has a face value of 100 yuan and an issuance interest rate of 1.49% [1] - The funds raised will be fully received on November 20, 2025 [1] Group 2: Regulatory Approval - The financing bond application was registered and approved by the trading association on October 21, 2025 [1] - The approved registration amount for the bond is 10 billion yuan, valid for two years [1]

Core Points - The company has received approval to issue super short-term financing bonds with a registered amount of RMB 5 billion, valid for two years from the date of acceptance notification [1][2]. Group 1 - The company held meetings on October 25, 2024, and November 12, 2024, where the board and shareholders approved the proposal to authorize management to handle the bond registration and issuance [1]. - The company applied for the registration of super short-term financing bonds with the China Interbank Market Dealers Association and received the acceptance notice on July 22, 2025 [1]. - The issuance of the 2025 annual seventh phase super short-term financing bonds has been completed, with related documents available on the China Money website and Shanghai Clearing House website [2].

Core Viewpoint - Zhejiang Zhongtuo has announced the completion of the issuance of the seventh phase of ultra-short-term financing bonds for the year 2025 [2] Group 1 - The company completed the issuance of ultra-short-term financing bonds [2] - The announcement was made on the evening of September 17 [2]

Group 1 - The company, Nanjing Pharmaceutical, announced the issuance of its 2025 seventh phase ultra-short-term financing bond on August 7, 2025, with a total issuance amount of 500 million yuan [2]

Core Points - The company has announced the issuance of its 2025 seventh phase ultra-short-term financing bond with a total planned issuance amount of 2 billion yuan [2] - The actual issuance amount is confirmed to be 2 billion yuan, with an interest rate of 1.52% and a price of 100.00 yuan per 100 yuan face value [2] - The bond has a term of 177 days, with the interest start date on July 23, 2025, and the repayment date on January 16, 2026 [2] Company Actions - The company's board of directors approved the application for the registration and issuance of debt financing instruments for the years 2024-2026 during the board meeting held on April 26, 2024 [1] - The company has received acceptance from the China Interbank Market Dealers Association for the registration of its debt financing instruments, which will be valid for two years from the date of the notification [1]